Response to: Revisiting the Methodology and Implications of the Network Meta-analysis on Dupuytren Disease Treatments: A Letter to the Editor.
作者信息
Nann Silas, Kovoor Joshua, Fowler James, Kieu James, Gupta Aashray, Hewitt Joseph, Ovenden Christopher, Edwards Suzanne, Bacchi Stephen, Jacobsen Jonathan Henry W, Harries Richard, Maddern Guy
机构信息
The University of Adelaide, South Australia, Australia.
Gold Coast University Hospital, Queensland, Australia.
出版信息
Hand (N Y). 2024 Nov;19(8):1338-1339. doi: 10.1177/15589447231218397. Epub 2023 Dec 15.
Abstract
摘要
相似文献
1
Response to: Revisiting the Methodology and Implications of the Network Meta-analysis on Dupuytren Disease Treatments: A Letter to the Editor.对《重新审视网络荟萃分析在掌腱膜挛缩症治疗中的方法学及意义：致编辑的一封信》的回应
Hand (N Y). 2024 Nov;19(8):1338-1339. doi: 10.1177/15589447231218397. Epub 2023 Dec 15.
2
Revisiting the Methodology and Implications of the Network Meta-Analysis on Dupuytren Disease Treatments: A Letter to the Editor.重新审视网络荟萃分析在掌腱膜挛缩症治疗中的方法和意义：致编辑的一封信
Hand (N Y). 2024 Nov;19(8):1336-1337. doi: 10.1177/15589447231218398. Epub 2023 Dec 15.
3
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.评估慢性阻塞性肺疾病干预措施的比较效果：面向临床医生的网状Meta分析教程
Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x.
4
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.用于复发缓解型多发性硬化症的免疫调节剂和免疫抑制剂：一项网状荟萃分析。
Cochrane Database Syst Rev. 2015 Sep 18;2015(9):CD011381. doi: 10.1002/14651858.CD011381.pub2.
5
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.慢性阻塞性肺疾病的长效吸入疗法（β受体激动剂、抗胆碱能药物和类固醇）：一项网状荟萃分析。
Cochrane Database Syst Rev. 2014 Mar 26;2014(3):CD010844. doi: 10.1002/14651858.CD010844.pub2.
6
Surgical Management of Dupuytren Disease: A Systematic Review and Network Meta-analyses.《掌腱膜挛缩症的外科治疗：系统评价和网络荟萃分析》。
Hand (N Y). 2024 Nov;19(8):1283-1292. doi: 10.1177/15589447231174175. Epub 2023 May 28.
7
A Systematic Review and Meta-Analysis on the Strength and Consistency of the Associations between Dupuytren Disease and Diabetes Mellitus, Liver Disease, and Epilepsy.一项关于杜普伊特伦挛缩症与糖尿病、肝脏疾病和癫痫之间关联强度和一致性的系统评价和荟萃分析。
Plast Reconstr Surg. 2018 Mar;141(3):367e-379e. doi: 10.1097/PRS.0000000000004120.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病：网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.早期和极早期肝细胞癌的消融和非手术治疗：系统评价和网络荟萃分析。
Health Technol Assess. 2023 Dec;27(29):1-172. doi: 10.3310/GK5221.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗：一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
本文引用的文献
1
Surgical Management of Dupuytren Disease: A Systematic Review and Network Meta-analyses.《掌腱膜挛缩症的外科治疗：系统评价和网络荟萃分析》。
Hand (N Y). 2024 Nov;19(8):1283-1292. doi: 10.1177/15589447231174175. Epub 2023 May 28.
2
Percutaneous Aponeurotomy and Lipofilling versus Limited Fasciectomy for Dupuytren's Contracture: 5-Year Results from a Randomized Clinical Trial.经皮腱膜切开术联合脂肪填充与局限性筋膜切除术治疗掌腱膜挛缩症的随机临床试验 5 年结果。
Plast Reconstr Surg. 2018 Dec;142(6):1523-1531. doi: 10.1097/PRS.0000000000004982.
3
Percutaneous Aponeurotomy and Lipofilling (PALF) versus Limited Fasciectomy in Patients with Primary Dupuytren's Contracture: A Prospective, Randomized, Controlled Trial.经皮腱膜切开术与脂肪填充术（PALF）对比原发性Dupuytren挛缩症患者的有限筋膜切除术：一项前瞻性、随机、对照试验
Plast Reconstr Surg. 2016 Jun;137(6):1800-1812. doi: 10.1097/PRS.0000000000002224.
4
Collagenase Clostridium Histolyticum versus Limited Fasciectomy for Dupuytren's Contracture: Outcomes from a Multicenter Propensity Score Matched Study.胶原酶溶组织梭菌与局限性筋膜切开术治疗杜普伊特伦挛缩：来自多中心倾向评分匹配研究的结果。
Plast Reconstr Surg. 2015 Jul;136(1):87-97. doi: 10.1097/PRS.0000000000001320.
5
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.Cochrane 协作网评估随机试验偏倚风险的工具。
BMJ. 2011 Oct 18;343:d5928. doi: 10.1136/bmj.d5928.
6
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.GRADE：关于证据质量评级和推荐强度的新共识。
BMJ. 2008 Apr 26;336(7650):924-6. doi: 10.1136/bmj.39489.470347.AD.
Zotero 插件